In the midst of COVID-19, the quest for cancer vaccines and treatment still continues.
| This week's FierceBiotech is brought to you by TD2.
Trouble viewing? Click here. |
| Clinical Keeping Research on Track |
|
|
| COVID-19 is changing life as we know it yet cancer still remains a serious threat to millions of people as well. Thankfully, technology is enabling trials to continue and so much can be accomplished virtually. And when teams are needed onsite, the right measures in place keep employees safe and trials on track. |
| | |
|
| | What to Consider for Cancer Vaccines While the biotech community at large focuses on vaccines for COVID-19, the quest for cancer vaccines and cancer treatment vaccines continues. What questions should you ask yourself before embarking on such a clinical trial? |
| | |
|
| |
| Free White Paper: What to Consider for Cancer Vaccines Keep your research on track with this free white paper from TD2 and find out what questions should be considered when developing a trial for cancer vaccines.
| |
|
| |
| | | Contact Us Want to you keep your trial moving forward during COVID-19? If you're seeking a partner who can help under the current circumstances and knows what questions to ask in developing a cancer vaccine trial, contact us today. Our expert team aims to save you time, money and resources while keeping you safe. Contact us to get started today.
|
| | |
|
| Unmatched Scientific Expertise | Accelerated Development | Committed to Your Goals | Patient-Centered |
|
|
| Want to reach 137,000+ FierceBiotech subscribers with your own message?
Contact aalcover@fiercemarkets.com or call 202-824-5074.
You are currently subscribed as newsletter@newslettercollector.com.
If you no longer wish to receive communications from FierceBiotech's trusted partners, simply click here to unsubscribe.
Refer to our Privacy Policy.
FierceMarkets, a division of Questex, LLC
1900 L St. NW Suite 400
Washington, DC 20036 |
